| Tue, Feb 9, 2010 |
| |
Lightning Round: Acodra Therapeutics, Dole Food, Valmont Industries and More at CNBC (Tue 9:24pm)
|
| |
'Mad Money Lightning Round': Rambus Heading Higher at TheStreet.com (Tue 7:35pm)
|
| |
Cramer's 'Mad Money' Recap: The Catalysts Behind the Rally (Final) at TheStreet.com (Tue 7:26pm)
|
| Mon, Feb 8, 2010 |
| |
[video] Acorda Therapeutics CEO on Drug Pricing at CNBC (Mon, Feb 8)
|
| |
4 Winning Biotechs For Your Portfolio: Senior Analyst at CNBC (Mon, Feb 8)
|
| |
Is Biotech Back? CNBC (Mon, Feb 8)
|
| |
[video] Is Biotech Back? at CNBC (Mon, Feb 8)
|
| |
Wild Weekly Wrap-Up: Everyone Just Relax at Seeking Alpha (Mon, Feb 8)
|
| Thu, Feb 4, 2010 |
| |
Acorda Therapeutics downgraded by Robert W. Baird Briefing.com (Thu, Feb 4)
|
| Wed, Feb 3, 2010 |
| |
Acorda's Lucky Number 13 at CNBC (Wed, Feb 3)
|
| |
Acorda Therapeutics to Present at the 12th Annual BIO CEO & Investor Conference Business Wire (Wed, Feb 3)
|
| |
ACORDA THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online (Wed, Feb 3)
|
| |
Acorda Therapeutics Announces Pricing and Patient Assistance Programs for AMPYRA (dalfampridine) Business Wire (Wed, Feb 3)
|
| Fri, Jan 29, 2010 |
| |
ACORDA THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online (Fri, Jan 29)
|
| Thu, Jan 28, 2010 |
| |
Pharma & Biotech Stock Review Zacks.com (Thu, Jan 28)
|
| |
Acorda Should Reap Rewards for MS Drug Ampyra at Seeking Alpha (Thu, Jan 28)
|
| |
5-Star Stocks Poised to Pop: HQ Sustainable Maritime at Motley Fool (Thu, Jan 28)
|
| Wed, Jan 27, 2010 |
| |
Industry Expert Identifies "Companion Diagnostics" Testing As New High Growth Sector In Health Care Services: KRAS Mutation Testing As Predictive Biomarker For EGFR Inhibitors Is First Wave Wall Street Transcript (Wed, Jan 27)
|
| |
Acorda's MS Drug May Not Be the Windfall Investors Expect at Seeking Alpha (Wed, Jan 27)
|
| Tue, Jan 26, 2010 |
| |
Tightening Tuesday: Global Edition at Seeking Alpha (Tue, Jan 26)
|
| Older Headlines |
|
|
|
|